Suppr超能文献

病毒在气溶胶中用含蛋白的雾化介质中的保存。

Viral Preservation with Protein-Supplemented Nebulizing Media in Aerosols.

机构信息

Sandia National Laboratories, Albuquerque, New Mexico, USA.

出版信息

Appl Environ Microbiol. 2023 Mar 29;89(3):e0154522. doi: 10.1128/aem.01545-22. Epub 2023 Mar 1.

Abstract

The outbreak of SARS-CoV-2 has emphasized the need for a deeper understanding of infectivity, spread, and treatment of airborne viruses. Bacteriophages (phages) serve as ideal surrogates for respiratory pathogenic viruses thanks to their high tractability and the structural similarities tailless phages bear to viral pathogens. However, the aerosolization of enveloped SARS-CoV-2 surrogate phi6 usually results in a >3-log reduction in viability, limiting its usefulness as a surrogate for aerosolized coronavirus in "real world" contexts, such as a sneeze or cough. Recent work has shown that saliva or artificial saliva greatly improves the stability of viruses in aerosols and microdroplets relative to standard dilution/storage buffers like suspension medium (SM) buffer. These findings led us to investigate whether we could formulate media that preserves the viability of phi6 and other phages in artificially derived aerosols. Results indicate that SM buffer supplemented with bovine serum albumin (BSA) significantly improves the recovery of airborne phi6, MS2, and 80α and outperforms commercially formulated artificial saliva. Particle sizing and acoustic particle trapping data indicate that BSA supplementation dose-dependently improves viral survivability by reducing the extent of particle evaporation. These data suggest that our viral preservation medium may facilitate a lower-cost alternative to artificial saliva for future applied aerobiology studies. We have identified common and inexpensive lab reagents that confer increased aerosol survivability on phi6 and other phages. Our results suggest that soluble protein is a key protective component in nebulizing medium. Protein supplementation likely reduces exposure of the phage to the air-water interface by reducing the extent of particle evaporation. These findings will be useful for applications in which researchers wish to improve the survivability of these (and likely other) aerosolized viruses to better approximate highly transmissible airborne viruses like SARS-CoV-2.

摘要

SARS-CoV-2 的爆发强调了需要更深入地了解空气传播病毒的传染性、传播和治疗。噬菌体(phages)由于其高度的可操作性以及无尾噬菌体与病毒病原体之间的结构相似性,成为呼吸致病性病毒的理想替代品。然而,包膜 SARS-CoV-2 替代物 phi6 的气溶胶化通常会导致其存活率降低>3 个对数级,限制了其在“真实世界”环境中作为气溶胶化冠状病毒替代物的用途,例如打喷嚏或咳嗽。最近的工作表明,与悬浮介质(SM)缓冲液等标准稀释/储存缓冲液相比,唾液或人工唾液可大大提高病毒在气溶胶和微滴中的稳定性。这些发现促使我们研究是否可以配制出能保持 phi6 和其他噬菌体在人工衍生气溶胶中活力的培养基。结果表明,SM 缓冲液中添加牛血清白蛋白(BSA)可显著提高空气传播 phi6、MS2 和 80α 的回收率,并且优于市售人工唾液。颗粒尺寸和声学颗粒捕获数据表明,BSA 补充剂剂量依赖性地通过减少颗粒蒸发程度来提高病毒的存活率。这些数据表明,我们的病毒保存培养基可能为未来的空气生物学研究提供一种更经济的替代人工唾液的方法。我们已经确定了常见且廉价的实验室试剂,这些试剂可提高 phi6 和其他噬菌体的气溶胶存活率。我们的结果表明,可溶性蛋白质是雾化介质中提高病毒存活率的关键保护成分。蛋白质补充剂可能通过减少颗粒蒸发程度来减少噬菌体暴露于气-水界面的程度。这些发现将有助于那些希望提高这些(可能还有其他)气溶胶化病毒的存活率以更好地模拟高传染性空气传播病毒(如 SARS-CoV-2)的研究人员。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc60/10057872/902c9dc9e2a2/aem.01545-22-f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验